Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Zwicker, Felix [VerfasserIn]   i
 Hoefel, Sebastian [VerfasserIn]   i
 Kirchner, Corinna [VerfasserIn]   i
 Huber, Peter E. [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Schempp, Michael [VerfasserIn]   i
Titel:Hypofractionated radiotherapy with simultaneous-integrated boost after breast-conserving surgery compared to standard boost-applications using helical tomotherapy with TomoEdge
Verf.angabe:Felix Zwicker, Sebastian Hoefel, Corinna Kirchner, Peter E. Huber, Juergen Debus and Michael Schempp
E-Jahr:2021
Jahr:April 3, 2021
Umfang:12 S.
Teil:volume:41
 year:2021
 number:4
 pages:1909-1920
 extent:12
Fussnoten:Gesehen am 17.05.2021
Titel Quelle:Enthalten in: Anticancer research
Ort Quelle:Attiki, 2004
Jahr Quelle:2021
Band/Heft Quelle:41(2021), 4, Seite 1909-1920
ISSN Quelle:1791-7530
Abstract:Background/Aim: This comparative plan study examines a range of boost-radiation methods in adjuvant radiotherapy of breast cancer using helical intensity-modulated radiotherapy with TomoEdge-technique. Impact of hypofractionated radiation with simultaneous-integrated boost (SIB) and influence of differing assumed α/β-values were examined. Patients and Methods: For 10 patients with left-sided breast cancer each four helical IMRT-plans with TomoEdge-technique were created: hypofractionated+SIB (H-SIB) (42.4/54.4 Gy, 16 fractions), normofractionated+SIB (N-SIB) (50.4/64.4 Gy, 28 fractions), hypofractionated+sequential-boost (H-SB) (42.4 Gy/16 fractions+16 Gy/8 fractions), normofractionated+ sequential-boost (N-SB) (50.4 Gy/28 fractions+16 Gy/8 fractions). Equivalent doses (EQD2) to organs-at-risk (OAR) and irradiated mammary-gland were analysed for different assumed α/β-values. Results: The mean EQD2 to OAR was significantly lower using hypofractionated radiation-techniques. H-SIB and H-SB were not significantly different. H-SIB and N-SIB conformed significantly better to the breast planning-target volume (PTV) and boost-volume (BV) than H-SB and N-SB. Regarding BV, mean EQD2 was significantly higher for all α/β-values investigated when using H-SIB and N-SIB. Regarding PTV, there were no clinically relevant differences. Conclusion: Relating to dosimetry, H-SIB is effective compared to standard-boost-techniques.
DOI:doi:10.21873/anticanres.14957
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.21873/anticanres.14957
 Volltext: https://ar.iiarjournals.org/content/41/4/1909
 DOI: https://doi.org/10.21873/anticanres.14957
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:breast cancer
 helical tomotherapy
 Hypofractionated radiotherapy
 IMRT
 SIB
 simultaneous integrated boost
 TomoEdge
K10plus-PPN:1757941452
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68738305   QR-Code
zum Seitenanfang